Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Alternative livelihood training programme for rural women who are employed in the tobacco industry in India

Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India ( Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India )
23 Oct 2024

Navigating cancer treatment choices

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India
Navigating cancer treatment choices ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )
10 Oct 2024

Choosing Wisely in endometrial & cervix cancers: BMC data

Dr Indu Bansal - Paras Health, Gurgaon, India
Choosing Wisely in endometrial & cervix cancers: BMC data ( Dr Indu Bansal - Paras Health, Gurgaon, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Surgery

Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India
Choosing Wisely in endometrial & cervix cancers: Surgery ( Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India
Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )
22 Sep 2024

PFS increase but no OS increase for niraparib in advanced ovarian cancer

Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain
PFS increase but no OS increase for niraparib in advanced ovarian cancer ( Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain )
17 Sep 2024

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers

Prof Gottfried Konecny - University of California, Los Angeles, USA
Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers ( Prof Gottfried Konecny - University of California, Los Angeles, USA )
16 Sep 2024

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer

Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA
Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer ( Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA )
16 Sep 2024

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India
Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )
10 Sep 2024

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )
7 Sep 2024

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata
Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )
7 Sep 2024